BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 21846782)

  • 1. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography.
    Ong A; Wong VW; Wong GL; Chan HL
    Liver Int; 2011 Aug; 31(7):1047-53. PubMed ID: 21733095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
    Wong VW; Vergniol J; Wong GL; Foucher J; Chan HL; Le Bail B; Choi PC; Kowo M; Chan AW; Merrouche W; Sung JJ; de Lédinghen V
    Hepatology; 2010 Feb; 51(2):454-62. PubMed ID: 20101745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ; Wiseman E; George J; Katelaris PH; Seow F; Fung C; Ngu MC
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.
    Wong VW; Wong GL; Tsang SW; Fan T; Chu WC; Woo J; Chan AW; Choi PC; Chim AM; Lau JY; Chan FK; Sung JJ; Chan HL
    Gut; 2011 Jun; 60(6):829-36. PubMed ID: 21339204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.
    Szczepaniak LS; Nurenberg P; Leonard D; Browning JD; Reingold JS; Grundy S; Hobbs HH; Dobbins RL
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E462-8. PubMed ID: 15339742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
    Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
    Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.
    Vizzutti F; Arena U; Nobili V; Tarquini R; Trappoliere M; Laffi G; Marra F; Pinzani M
    Ann Hepatol; 2009; 8(2):89-94. PubMed ID: 19502649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index.
    Petta S; Di Marco V; Cammà C; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1350-60. PubMed ID: 21517924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.
    Wong VW; Wong GL; Chim AM; Tse AM; Tsang SW; Hui AY; Choi PC; Chan AW; So WY; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2008 Jul; 103(7):1682-8. PubMed ID: 18616651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
    Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A;
    J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
    Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
    Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
    Lu H; Zeng L; Liang B; Shu X; Xie D
    Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.